Assessment of Botulinum Toxin Injection for Treatment of Temporomandibular Joint Dislocation

• Status: Recruiting
• Trial end date: 2024-03-31
• Target enrollment: 0
• Participant gender: All

Summary

Assessment of the effect of Botulinum toxin injection on the frequency of luxation and TMJ Pain in patients with TMJ dislocation either chronic recurrent dislocation or subluxation

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cairo University
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A

Criteria

Inclusion Criteria:

1. patients with TMJ habitual or recurrent dislocation

2. Age ≥ 18 years

3. The willingness of the patient to receive relative painful injections and to follow instructions

Exclusion Criteria:

1. Patients with neurogenic cause of TMJ Hypermobility.

2. Drug-induced TMJ Hypermobility